Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clonazepam + Paroxetine is a combination medication used primarily for treating depression, anxiety disorders, and panic disorders. This combination brings together two distinct drug classes: clonazepam (a benzodiazepine) and paroxetine (a selective serotonin reuptake inhibitor or SSRI).\n\n## Pharmacology and Mechanism of Action\n\nThe combination works through complementary mechanisms:\n\n- **Clonazepam** increases levels of gamma-aminobutyric acid (GABA), a calming chemical in the brain that helps reduce anxiety, muscle spasms, and seizure activity[3][5].\n- **Paroxetine** functions as an antidepressant by increasing serotonin levels in the brain, which helps improve mood, behavior, and prevent symptoms of depression[3][4].\n\nThis dual-action approach is particularly useful in treating conditions where both anxiety and depression are present.\n\n## Clinical Applications\n\nThe combination is primarily used for:\n\n- Depression[3][4][5]\n- Panic disorder[2][5]\n- Anxiety disorders[5]\n- Post-traumatic stress disorder (PTSD)[6]\n\nResearch has shown that combined treatment with paroxetine and clonazepam can result in more rapid response than with paroxetine (SSRI) alone in panic disorder, though this benefit may not extend beyond the initial few weeks of therapy[2]. Interestingly, this accelerated response was not observed in generalized social anxiety disorder (GSAD)[7].\n\n## Common Side Effects\n\nCommon side effects of this combination include:\n\n- Nausea and vomiting\n- Diarrhea\n- Confusion\n- Memory impairment\n- Uncoordinated body movements\n- Drowsiness and tiredness\n- Sexual dysfunction (decreased orgasm, low sexual desire, delayed ejaculation)[3][4][5]\n\n## Drug Interactions\n\nUsing clonazepam together with paroxetine may increase side effects such as dizziness, drowsiness, confusion, and difficulty concentrating[1][8]. This combination is classified as a \"moderately clinically significant\" interaction, meaning it should usually be avoided unless used under special circumstances with appropriate monitoring[8].\n\n## Available Formulations\n\nThe combination is available under various brand names including:\n- Zaptra\n- Panazep\n- Pexep Plus\n- Pari Plus\n- Xet Plus\n- Depaxil Plus\n- Patroxta Plus\n- Clonotril P\n- Parozep\n- Paxonil Plus[4]\n\nThis medication is typically prescribed for adults and is not usually recommended for children or teenagers unless specifically advised by a doctor[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Clonazepam + Paroxetine.